CDDF’s New Publication: White Paper – “Empowering Involvement and Engagement of Patients with Cancer in Oncology Drug Development”
The CDDF is delighted to announce that the White Paper, “Empowering Involvement and Engagement of Patients with Cancer in Oncology Drug Development”, has been published in October 2023. It has been prepared by Prof. Mark Lawler on behalf of the Cancer Drug Development...
CDDF Workshop on Innovative Oncology Trial Designs: Key Takeaways from Day 1’s Program
📢 The Cancer Drug Development Forum (CDDF) workshop on “Innovative Oncology Trial Designs” concluded successfully on its first day, bringing together key stakeholders in cancer drug development for in-depth discussions on a range of topics. Here are key takeaways and...
Key Takeaways from the CDDF Webinar on Critical Impacts of the IVDR Implementation on Patient Access to Clinical Trials (7 September 2023)
The Cancer Drug Development Forum (CDDF) held a live webinar on “Critical Impacts of the In Vitro Diagnostic Regulation (IVDR) Implementation on Patient Access to Clinical Trials“ on Thursday 07 September 2023. In this webinar, Audrey Wolf (EFPIA) presented the...